nodes	percent_of_prediction	percent_of_DWPC	metapath
Mepenzolate—Asthenia—Altretamine—ovarian cancer	0.033	0.033	CcSEcCtD
Mepenzolate—Dizziness—Altretamine—ovarian cancer	0.0304	0.0304	CcSEcCtD
Mepenzolate—Vomiting—Altretamine—ovarian cancer	0.0293	0.0293	CcSEcCtD
Mepenzolate—Nausea—Altretamine—ovarian cancer	0.0273	0.0273	CcSEcCtD
Mepenzolate—Ageusia—Docetaxel—ovarian cancer	0.0246	0.0246	CcSEcCtD
Mepenzolate—Ageusia—Epirubicin—ovarian cancer	0.0166	0.0166	CcSEcCtD
Mepenzolate—Confusional state—Chlorambucil—ovarian cancer	0.0165	0.0165	CcSEcCtD
Mepenzolate—Ageusia—Doxorubicin—ovarian cancer	0.0153	0.0153	CcSEcCtD
Mepenzolate—Abdominal distension—Paclitaxel—ovarian cancer	0.0148	0.0148	CcSEcCtD
Mepenzolate—Anaphylactic shock—Topotecan—ovarian cancer	0.0146	0.0146	CcSEcCtD
Mepenzolate—Anaphylactic shock—Melphalan—ovarian cancer	0.0143	0.0143	CcSEcCtD
Mepenzolate—Tachycardia—Melphalan—ovarian cancer	0.0139	0.0139	CcSEcCtD
Mepenzolate—Palpitations—Vinorelbine—ovarian cancer	0.0135	0.0135	CcSEcCtD
Mepenzolate—Feeling abnormal—Chlorambucil—ovarian cancer	0.0135	0.0135	CcSEcCtD
Mepenzolate—Urticaria—Chlorambucil—ovarian cancer	0.013	0.013	CcSEcCtD
Mepenzolate—Anaphylactic shock—Vinorelbine—ovarian cancer	0.0125	0.0125	CcSEcCtD
Mepenzolate—Constipation—Topotecan—ovarian cancer	0.0125	0.0125	CcSEcCtD
Mepenzolate—Tachycardia—Vinorelbine—ovarian cancer	0.0122	0.0122	CcSEcCtD
Mepenzolate—Hypersensitivity—Chlorambucil—ovarian cancer	0.0121	0.0121	CcSEcCtD
Mepenzolate—Feeling abnormal—Topotecan—ovarian cancer	0.012	0.012	CcSEcCtD
Mepenzolate—Asthenia—Chlorambucil—ovarian cancer	0.0117	0.0117	CcSEcCtD
Mepenzolate—Urticaria—Topotecan—ovarian cancer	0.0116	0.0116	CcSEcCtD
Mepenzolate—Urticaria—Melphalan—ovarian cancer	0.0113	0.0113	CcSEcCtD
Mepenzolate—Hypersensitivity—Topotecan—ovarian cancer	0.0107	0.0107	CcSEcCtD
Mepenzolate—Constipation—Vinorelbine—ovarian cancer	0.0107	0.0107	CcSEcCtD
Mepenzolate—Hypersensitivity—Melphalan—ovarian cancer	0.0105	0.0105	CcSEcCtD
Mepenzolate—Asthenia—Topotecan—ovarian cancer	0.0105	0.0105	CcSEcCtD
Mepenzolate—Vomiting—Chlorambucil—ovarian cancer	0.0104	0.0104	CcSEcCtD
Mepenzolate—Feeling abnormal—Vinorelbine—ovarian cancer	0.0103	0.0103	CcSEcCtD
Mepenzolate—Asthenia—Melphalan—ovarian cancer	0.0102	0.0102	CcSEcCtD
Mepenzolate—Tension—Paclitaxel—ovarian cancer	0.0101	0.0101	CcSEcCtD
Mepenzolate—Nervousness—Paclitaxel—ovarian cancer	0.00997	0.00997	CcSEcCtD
Mepenzolate—Urticaria—Vinorelbine—ovarian cancer	0.0099	0.0099	CcSEcCtD
Mepenzolate—Nausea—Chlorambucil—ovarian cancer	0.00972	0.00972	CcSEcCtD
Mepenzolate—Vision blurred—Paclitaxel—ovarian cancer	0.00968	0.00968	CcSEcCtD
Mepenzolate—Dizziness—Topotecan—ovarian cancer	0.00963	0.00963	CcSEcCtD
Mepenzolate—Vomiting—Topotecan—ovarian cancer	0.00926	0.00926	CcSEcCtD
Mepenzolate—Hypersensitivity—Vinorelbine—ovarian cancer	0.00918	0.00918	CcSEcCtD
Mepenzolate—Headache—Topotecan—ovarian cancer	0.00913	0.00913	CcSEcCtD
Mepenzolate—Palpitations—Paclitaxel—ovarian cancer	0.00908	0.00908	CcSEcCtD
Mepenzolate—Vomiting—Melphalan—ovarian cancer	0.00907	0.00907	CcSEcCtD
Mepenzolate—Asthenia—Vinorelbine—ovarian cancer	0.00894	0.00894	CcSEcCtD
Mepenzolate—Nausea—Topotecan—ovarian cancer	0.00865	0.00865	CcSEcCtD
Mepenzolate—Dry mouth—Paclitaxel—ovarian cancer	0.00855	0.00855	CcSEcCtD
Mepenzolate—Abdominal distension—Epirubicin—ovarian cancer	0.00848	0.00848	CcSEcCtD
Mepenzolate—Nausea—Melphalan—ovarian cancer	0.00847	0.00847	CcSEcCtD
Mepenzolate—Confusional state—Paclitaxel—ovarian cancer	0.00845	0.00845	CcSEcCtD
Mepenzolate—Anaphylactic shock—Paclitaxel—ovarian cancer	0.00838	0.00838	CcSEcCtD
Mepenzolate—Dizziness—Vinorelbine—ovarian cancer	0.00824	0.00824	CcSEcCtD
Mepenzolate—Tachycardia—Paclitaxel—ovarian cancer	0.00818	0.00818	CcSEcCtD
Mepenzolate—Vomiting—Vinorelbine—ovarian cancer	0.00792	0.00792	CcSEcCtD
Mepenzolate—Abdominal distension—Doxorubicin—ovarian cancer	0.00785	0.00785	CcSEcCtD
Mepenzolate—Headache—Vinorelbine—ovarian cancer	0.00781	0.00781	CcSEcCtD
Mepenzolate—Palpitations—Docetaxel—ovarian cancer	0.00769	0.00769	CcSEcCtD
Mepenzolate—Insomnia—Paclitaxel—ovarian cancer	0.00758	0.00758	CcSEcCtD
Mepenzolate—Drowsiness—Epirubicin—ovarian cancer	0.00751	0.00751	CcSEcCtD
Mepenzolate—Somnolence—Paclitaxel—ovarian cancer	0.00745	0.00745	CcSEcCtD
Mepenzolate—Nausea—Vinorelbine—ovarian cancer	0.0074	0.0074	CcSEcCtD
Mepenzolate—Dry mouth—Docetaxel—ovarian cancer	0.00725	0.00725	CcSEcCtD
Mepenzolate—Constipation—Paclitaxel—ovarian cancer	0.00717	0.00717	CcSEcCtD
Mepenzolate—Confusional state—Docetaxel—ovarian cancer	0.00716	0.00716	CcSEcCtD
Mepenzolate—Anaphylactic shock—Docetaxel—ovarian cancer	0.0071	0.0071	CcSEcCtD
Mepenzolate—Drowsiness—Doxorubicin—ovarian cancer	0.00695	0.00695	CcSEcCtD
Mepenzolate—Tachycardia—Docetaxel—ovarian cancer	0.00693	0.00693	CcSEcCtD
Mepenzolate—Feeling abnormal—Paclitaxel—ovarian cancer	0.00691	0.00691	CcSEcCtD
Mepenzolate—Urticaria—Paclitaxel—ovarian cancer	0.00666	0.00666	CcSEcCtD
Mepenzolate—Insomnia—Docetaxel—ovarian cancer	0.00643	0.00643	CcSEcCtD
Mepenzolate—Somnolence—Docetaxel—ovarian cancer	0.00632	0.00632	CcSEcCtD
Mepenzolate—Hypersensitivity—Paclitaxel—ovarian cancer	0.00617	0.00617	CcSEcCtD
Mepenzolate—Constipation—Docetaxel—ovarian cancer	0.00607	0.00607	CcSEcCtD
Mepenzolate—Asthenia—Paclitaxel—ovarian cancer	0.00601	0.00601	CcSEcCtD
Mepenzolate—Feeling abnormal—Docetaxel—ovarian cancer	0.00585	0.00585	CcSEcCtD
Mepenzolate—Tension—Epirubicin—ovarian cancer	0.00576	0.00576	CcSEcCtD
Mepenzolate—Nervousness—Epirubicin—ovarian cancer	0.0057	0.0057	CcSEcCtD
Mepenzolate—Dizziness—Paclitaxel—ovarian cancer	0.00554	0.00554	CcSEcCtD
Mepenzolate—Vision blurred—Epirubicin—ovarian cancer	0.00553	0.00553	CcSEcCtD
Mepenzolate—Tension—Doxorubicin—ovarian cancer	0.00533	0.00533	CcSEcCtD
Mepenzolate—Vomiting—Paclitaxel—ovarian cancer	0.00533	0.00533	CcSEcCtD
Mepenzolate—Nervousness—Doxorubicin—ovarian cancer	0.00528	0.00528	CcSEcCtD
Mepenzolate—Headache—Paclitaxel—ovarian cancer	0.00525	0.00525	CcSEcCtD
Mepenzolate—Hypersensitivity—Docetaxel—ovarian cancer	0.00523	0.00523	CcSEcCtD
Mepenzolate—Palpitations—Epirubicin—ovarian cancer	0.00519	0.00519	CcSEcCtD
Mepenzolate—Vision blurred—Doxorubicin—ovarian cancer	0.00512	0.00512	CcSEcCtD
Mepenzolate—Asthenia—Docetaxel—ovarian cancer	0.0051	0.0051	CcSEcCtD
Mepenzolate—Nausea—Paclitaxel—ovarian cancer	0.00498	0.00498	CcSEcCtD
Mepenzolate—Dry mouth—Epirubicin—ovarian cancer	0.00489	0.00489	CcSEcCtD
Mepenzolate—Confusional state—Epirubicin—ovarian cancer	0.00483	0.00483	CcSEcCtD
Mepenzolate—Palpitations—Doxorubicin—ovarian cancer	0.0048	0.0048	CcSEcCtD
Mepenzolate—Anaphylactic shock—Epirubicin—ovarian cancer	0.00479	0.00479	CcSEcCtD
Mepenzolate—Dizziness—Docetaxel—ovarian cancer	0.0047	0.0047	CcSEcCtD
Mepenzolate—Tachycardia—Epirubicin—ovarian cancer	0.00468	0.00468	CcSEcCtD
Mepenzolate—Dry mouth—Doxorubicin—ovarian cancer	0.00452	0.00452	CcSEcCtD
Mepenzolate—Vomiting—Docetaxel—ovarian cancer	0.00452	0.00452	CcSEcCtD
Mepenzolate—Confusional state—Doxorubicin—ovarian cancer	0.00447	0.00447	CcSEcCtD
Mepenzolate—Headache—Docetaxel—ovarian cancer	0.00445	0.00445	CcSEcCtD
Mepenzolate—Anaphylactic shock—Doxorubicin—ovarian cancer	0.00443	0.00443	CcSEcCtD
Mepenzolate—Insomnia—Epirubicin—ovarian cancer	0.00433	0.00433	CcSEcCtD
Mepenzolate—Tachycardia—Doxorubicin—ovarian cancer	0.00433	0.00433	CcSEcCtD
Mepenzolate—Somnolence—Epirubicin—ovarian cancer	0.00426	0.00426	CcSEcCtD
Mepenzolate—Nausea—Docetaxel—ovarian cancer	0.00422	0.00422	CcSEcCtD
Mepenzolate—Constipation—Epirubicin—ovarian cancer	0.0041	0.0041	CcSEcCtD
Mepenzolate—Insomnia—Doxorubicin—ovarian cancer	0.00401	0.00401	CcSEcCtD
Mepenzolate—Feeling abnormal—Epirubicin—ovarian cancer	0.00395	0.00395	CcSEcCtD
Mepenzolate—Somnolence—Doxorubicin—ovarian cancer	0.00394	0.00394	CcSEcCtD
Mepenzolate—Urticaria—Epirubicin—ovarian cancer	0.00381	0.00381	CcSEcCtD
Mepenzolate—Constipation—Doxorubicin—ovarian cancer	0.00379	0.00379	CcSEcCtD
Mepenzolate—Feeling abnormal—Doxorubicin—ovarian cancer	0.00365	0.00365	CcSEcCtD
Mepenzolate—Hypersensitivity—Epirubicin—ovarian cancer	0.00353	0.00353	CcSEcCtD
Mepenzolate—Urticaria—Doxorubicin—ovarian cancer	0.00352	0.00352	CcSEcCtD
Mepenzolate—Asthenia—Epirubicin—ovarian cancer	0.00344	0.00344	CcSEcCtD
Mepenzolate—Hypersensitivity—Doxorubicin—ovarian cancer	0.00327	0.00327	CcSEcCtD
Mepenzolate—Asthenia—Doxorubicin—ovarian cancer	0.00318	0.00318	CcSEcCtD
Mepenzolate—Dizziness—Epirubicin—ovarian cancer	0.00317	0.00317	CcSEcCtD
Mepenzolate—Vomiting—Epirubicin—ovarian cancer	0.00305	0.00305	CcSEcCtD
Mepenzolate—Headache—Epirubicin—ovarian cancer	0.003	0.003	CcSEcCtD
Mepenzolate—Dizziness—Doxorubicin—ovarian cancer	0.00293	0.00293	CcSEcCtD
Mepenzolate—Nausea—Epirubicin—ovarian cancer	0.00285	0.00285	CcSEcCtD
Mepenzolate—Vomiting—Doxorubicin—ovarian cancer	0.00282	0.00282	CcSEcCtD
Mepenzolate—Headache—Doxorubicin—ovarian cancer	0.00278	0.00278	CcSEcCtD
Mepenzolate—Nausea—Doxorubicin—ovarian cancer	0.00263	0.00263	CcSEcCtD
